Free shipping on all orders over $ 500

NVP-CGM097

Cat. No. M13393
NVP-CGM097 Structure
Synonym:

CGM097

Size Price Availability Quantity
5mg USD 250  USD250 In stock
10mg USD 430  USD430 In stock
50mg USD 1650  USD1650 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

NVP-CGM097 is a highly effective and selective MDM2 inhibitor with a Ki value of 1.3 nM. In wild-type p53 cells, NVP-CGM097 significantly induced p53 reassignment into the nucleus with IC50 of 0.224 μM. Nvp-cgm097 inhibited HCT116 (p53WT/WT) cells with IC50 of 454 ± 136 nM.

Chemical Information
Molecular Weight 659.26
Formula C38H47ClN4O4
CAS Number 1313363-54-0
Solubility (25°C) DMSO ≥ 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Sebastian Bauer, et al. Br J Cancer. Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies

[2] Meng Zhang, et al. Front Oncol. NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance

[3] Clemens Reuther, et al. Neuroendocrinology. The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1

[4] Philipp Holzer, et al. J Med Chem. Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors

[5] Sbastien Jeay, et al. Elife. A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097

Related Mdm2 Products
MMRi64

MMRi64 disrupts Mdm2-MdmX interactions.

MeOIstPyrd

MeOIstPyrd is an anti-skin cancer agent.

MDM2/XIAP-IN-3

MDM2/XIAP-IN-3 is a dual MDM2/XIAP inhibitor.

UNP-6457

UNP-6457 is a potent active MDM2-p53 interaction inhibitor with an IC50 values of 8.9 nM.

YL93

YL93 is a dual inhibitors of MDM2/4 with Ki values of 0.64 μM and 1.1 nM for MDM4 and MDM2, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: NVP-CGM097, CGM097 supplier, Mdm2, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.